Emergent Health Corp (OTCPK: EMGE)
Health Care · Biotechnology · US
$0.00
— today · +9900.0% 1Y
Emergent Health Corp (OTCPK: EMGE) operates in the Biotechnology industry within the Health Care sector. The company is valued at $42.70K and employs 6 people.
Over the last twelve months the share price has gained 9900.0%, trading between 0.00 and 0.00.
Tweenvest scores Emergent Health Corp across four factors: quality 60/100, value 89/100. Its strongest factor is value.
EMGE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.70K
- Revenue (TTM)
- $119.57K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- -53.31
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 426.95M
- Employees
- 6
- Next earnings
- —
About Emergent Health Corp
Emergent Health Corp. focuses on the creation and distribution of advanced regenerative medicine, alongside a variety of nutraceuticals and plant-derived nutritional supplements. The company's product portfolio features Vita-Stim, a potent nutrient formulated to strengthen the immune system, promote stem cell vitality, and support general well-being. Another key offering is Neuvitale, which not only assists in nourishing stem cells but also serves as a methyl donor to safeguard DNA integrity. For appetite regulation, they provide Hungarest, a dietary aid designed to manage hunger signals originating from both the brain and stomach. Additionally, EmergentO2 is available as a water oxygenator, aiming to elevate oxygen levels within the bloodstream. The firm also develops and markets several solutions for diminishing facial wrinkles. These products are distributed through a wide network of health food stores, pharmacies, and diverse other retail channels, reaching consumers throughout the United States and globally. Based in King of Prussia, Pennsylvania, Emergent Health Corp. transitioned to private ownership as of August 26, 2014.
- ISIN
- US29100Q3083
- Founded
- 2006
- Listed since
- Sep 8, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.